Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
McGill University
$27,000.00
Uncovering therapeutic targets across infectious and immune-mediated diseases through immune cell genetics
EF 2025-26
Résumé
My project investigates how inherited differences in immune cell traits shape susceptibility to both infectious and immune-mediated diseases, with the goal of identifying new therapeutic targets. Immune responses vary widely across individuals. In infections such as pneumonia, sepsis, skin infections, urinary tract infections, and COVID-19, excessive inflammation can worsen outcomes, while in autoimmune disorders like rheumatoid arthritis and multiple sclerosis, the immune system mistakenly attacks healthy tissue. These conditions present very different clinical pictures, yet they share a common foundation of immune dysregulation. Understanding why some people mount harmful responses while others do not remains a major challenge in medicine.
To address this gap, I focus on neutrophil and lymphocyte counts, simple and highly heritable markers of immune function. Using large population cohorts, I will map the genetic factors that influence these traits and determine how they relate to disease risk. I will perform genome-wide association studies for immune cell traits, integrate genetic data across multiple infectious and autoimmune diseases, and use methods such as genetic correlation, colocalization, and Mendelian randomization to test for shared biological pathways.
I will also incorporate rare variant analyses and protein-level genetic data to pinpoint genes with convergent evidence across diseases. By combining these approaches, the project aims to identify immune pathways that contribute to both infectious disease severity and autoimmune pathology, and to highlight specific genes with potential for therapeutic development.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
573303
Name
Zaidi Anna
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Uncovering therapeutic targets across infectious and immune-mediated diseases through immune cell genetics
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Genetic Epidemiology; Genome-Wide Association Study (Gwas); Immune Response; Infection Susceptibility; Lymphocytes; Mendelian Randomization; Neutrophils; Pneumonia; Precision Medicine; Rare Variants
Abstract
My project investigates how inherited differences in immune cell traits shape susceptibility to both infectious and immune-mediated diseases, with the goal of identifying new therapeutic targets. Immune responses vary widely across individuals. In infections such as pneumonia, sepsis, skin infections, urinary tract infections, and COVID-19, excessive inflammation can worsen outcomes, while in autoimmune disorders like rheumatoid arthritis and multiple sclerosis, the immune system mistakenly attacks healthy tissue. These conditions present very different clinical pictures, yet they share a common foundation of immune dysregulation. Understanding why some people mount harmful responses while others do not remains a major challenge in medicine.
To address this gap, I focus on neutrophil and lymphocyte counts, simple and highly heritable markers of immune function. Using large population cohorts, I will map the genetic factors that influence these traits and determine how they relate to disease risk. I will perform genome-wide association studies for immune cell traits, integrate genetic data across multiple infectious and autoimmune diseases, and use methods such as genetic correlation, colocalization, and Mendelian randomization to test for shared biological pathways.
I will also incorporate rare variant analyses and protein-level genetic data to pinpoint genes with convergent evidence across diseases. By combining these approaches, the project aims to identify immune pathways that contribute to both infectious disease severity and autoimmune pathology, and to highlight specific genes with potential for therapeutic development.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zaidi, Anna
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~